UNASSIGNED: Liver resection (LR) and liver transplantation (LT) are curative treatments for @entity157 ( @entity157 ), although their performance remains debated. We compared the survival of @entity1 with @entity157 conforming to the Milan criteria (MC) after LT and LR and analyzed factors affecting clinical outcomes. Between January 2006 and January 2013, 65 and 184 @entity1 received LT and LR for HCCs fulfilling the MC, respectively. @entity1349 ( @entity1349 ) and disease-free survival (DFS) rates were compared between the two groups. To investigate effects of liver function and living donor liver transplantation (LDLT) on survival, two subgroup analyses were performed and associations with @entity1349 and DFS were examined. We found that @entity1349 rates were higher after LT than after LR since 3  years postoperatively. DFS rates were significantly better after LT than after LR. Performance of LR, vascular invasion, and @entity5 multiplicity were associated with poor DFS, and factors affecting @entity1349 included the presence of vascular invasions, liver @entity82 , and @entity5 multiplicity. In conclusion, despite of the effects of @entity5 characteristics on clinical outcomes, LT, including LDLT, should be considered the treatment of choice for @entity1 with HCCs who met the MC. The role of LR is to identify poor prognostic factors through pathological examination.

The role of liver transplantation or resection for XXXX with @entity157 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity82 :: ('MESH:D005355', 'Disease') :: ['cirrhosis'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'early hepatocellular carcinoma'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'Overall survival']
@entity1 :: (9606,Species) :: ['patients']
